Silymarin (LEGALON)

DRUG3 trials

Sponsors

Isfahan University of Medical Sciences, Shiraz University of Medical Sciences, Ain Shams University

Conditions

Beta-thalassemia MajorFibromyalgia (FM)Immune AbnormalitiesIron Overload

Phase 1

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major

CompletedNCT01752153

Shiraz University of Medical SciencesImmune Abnormalities

Start: 2012-06-30End: 2012-09-30Updated: 2012-12-19

Phase 2

Therapeutic Effects of Silymarin in Patients With B-thalassemia Major

Isfahan University of Medical SciencesBeta-thalassemia Major, Iron Overload

Start: 2009-03-31Target: 140Updated: 2009-10-21

Unknown Phase

Silymarin vs Hesperidin/Diosmin in Fibromyalgia

RecruitingNCT07293767

Ain Shams UniversityFibromyalgia (FM)

Start: 2024-11-16End: 2026-12-31Target: 90Updated: 2025-12-19